Tunicamycin (6) , an antiviral antibiotic, inhibits the glycosidation of glycoproteins in animal cells (7) . In bacteria, the antibiotic inhibits the biosyntheses of peptidoglycan (1, 8, 9) and teichoic acid (2) by preventing the formation of lipid intermediates from uridine diphospho-Nacetylmuramylpentapeptide and uridine diphospho-N-acetylglucosamine, respectively. Tunicamycin-resistant mutants were isolated from B. subtilis NA64 after treatment with N-methyl-N'-nitro-N-nitrosoguanidine. They grew normally in a nutrient broth (3 g of bouillon, 10 g of peptone, and 5 g of sodium chloride per liter at pH 7.0) containing 50 yg of tunicamycin per ml, whereas in the parental strain remarkable morphological changes and lysis were induced by the addition of 0.8 jig of tunicamycin per ml to the medium (4).
The mutants were classified into two types by production of extracellular a-amylase. Type 1, B7, produced five times as much extracellular a-amylase as NA64 did, and type 2 mutants, B4, B8, B9,and B10, showed production of extracellular a-amylase almost equal to that of NA64 ( Table 1 ). All of the mutants had the same production of extracellular protease and ribonuclease and the same sensitivity to other antibiotics as their parental strain. The chromosomal locations of the mutational sites for the two types of tunicamycin-resistant characters are described in this paper.
Strains used are listed in The a-amylase structural gene (amyE) was mapped near the aroI locus by Yuki (16) and Steinmetz et al. (5) . A regulator gene (amyR) is closely linked with amyE (10, 15). To characterize the genetic relation of the hyperproductivity of a-amylase to Tmr in B7, DNA from B7 was transferred into M07-2-31 by DNA-mediated transformation. Tmr and Aro+ transformants were separately isolated ( Table 2) . Tmr was cotransformable with amyE+ at an average frequency of 90% and with aroI+ at 8%. aroI+ was cotransformable with amyE+ and Tmr at frequencies of about 35 and 8%, respectively. These results implied an order of tmr-7-amy-E07-aroI906 (Fig. 1) . All of the transformants that acquired tmr-7 and amyE+ produced about 200 U of extracellular a-amylase per ml, as B7 did. Thus, the tunicamycin resistance and hyperproduction of the enzyme found in B7 were due to a single mutation, as suggested previously (4 tmr-8 showed an extremely high linkage with aroI in DNA-mediated transformation ( Table  2 ). The order of genetic markers around aroI was amyE07-tmr-8-aroI906. tmr-4, tmr-9, and tmr-10 were also mapped at about the same position as that of tmr-8. These mutations seemed to have occurred at different sites in the same gene. 1 strain, tmr-7 aroI906, by the DNA from a type 2 strain, tmr-8 aror.
The loci for tmr-7 and tmr-8 were further confirmed by transduction with PBS1 (Fig. 2) . tmr-7 and tmr-8 did not segregate from amyE+ and arolf, respectively.
Steinmetz et al. (5) reported that the cotransduction frequency of aroI with amy + was 92%. A comparable frequency, 85%, between these markers was observed by lysates of PBS1 on NA64 and B8. Higher values, however, were obtained in the same region and in the region including the aroI to tmr-7 markers when PBS 1 lysates on LTR-7 and B7 were used (shown in parentheses in Fig. 2 ). The phage did not seem to contain host DNA of abnormal length, because the cotransduction frequencies of lys-21 with metB5 were about 25%. The localization of other genetic markers in the lin-2-to-dal region determined by transduction are also included in Fig. 2 (strains used are not shown) .
Another tunicamycin-resistant mutant, which grew in nutrient broth containing 25 yg of tunicamycin per ml, was isolated. Genetic characterization of this mutant was not successful, since the resistance to tunicamycin was not due to a single mutation.
These results indicate the presence of at least two different chromosomal loci for the phenotypic tunicamycin resistance character. It seems noteworthy that hyperproduction of extracellular a-amylase occurs only in the type 1 tunicamycin resistance mutation. To understand the function of this antibiotic in B. subtilis, whether the resistant character is directly related to the prevention of inhibition of lipid intermediate synthesis is now under investigation.
